Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks. Head and neck (…)
Site référencé:
The Guardian
3566.jpg?width=140&quality=85&auto=format&fit=max&s=6b8d8aa1d243e52630ec912240d7c64f, 3566.jpg?width=460&quality=85&auto=format&fit=max&s=2d87713509e54a6825bcd7efa979683a, 3566.jpg?width=700&quality=85&auto=format&fit=max&s=0f55e3e23cd4fdddf1f92afd52d64c83
The Guardian
‘No one makes money from them’ : with MTV channels switching off, is the music video under threat ?
18/10/2025
Pushy parents are ‘biggest problem in sports performance’, say psychologists
18/10/2025
Are we living in a golden age of stupidity ?
18/10/2025
‘We don’t celebrate Black creativity enough’ : why the Black British book festival is bigger than ever
18/10/2025
‘A world detached from struggles of urban life’ : a rare exhibition of Renoir drawings
18/10/2025
Happy birthday to the NES, companion to millions of Nintendo childhoods
18/10/2025